What is the public's right to access medical discoveries based on federally funded research?

JAMA

Volumn 311, Issue 9, 2014, Pages 907-908

  Treasure, Carolyn L ^a   Avorn, Jerry ^a   Kesselheim, Aaron S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE BETA; LATANOPROST; RITONAVIR;

DRUG MANUFACTURE; DRUG MARKETING; FABRY DISEASE; FOOD AND DRUG ADMINISTRATION; FUNDING; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; NOTE; PATENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

CONSUMER PARTICIPATION; DRUG INDUSTRY; FEDERAL GOVERNMENT; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PATENTS AS TOPIC; PATIENT RIGHTS; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 84895478316     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.404     Document Type: Note

References (8)

1. Stevens AJ, Jensen JJ, Wyller K, et al. The role of public-sector research in the discovery of drugs and vaccines. N Engl J Med. 2011;364(6):535-541.
2. Markel H. Patents, profits, and the American people-the Bayh-Dole Act of 1980. N Engl J Med. 2013;369(9):794-796.
3. Leahy P. Letter to Dr. Francis S. Collins, M.D., Ph.D. http://www.leahy.senate.gov/download/07-12-13-pjl-to-nih-re--myriad-march-in. Accessed January 27, 2014.
4. Varmus H. Determination in the Case of Petition of CellPro, Inc. http://web.archive.org/web/20070102183356/http://www.nih.gov/icd/od/foia/ cellpro/pdfs/foia-cellpro39.pdf. August 1, 1997. Accessed January 27, 2014.
5. Zerhouni EA. In the Case of Norvir Manufactured by Abbott Laboratories, Inc. http://www.essentialinventions.org/docs/usa-ritonavir/zerhouni29jul04.pdf. July 29, 2004. Accessed January 27, 2014.
6. Arno PS, Davis MH. Why don't we enforce existing drug price controls? the unrecognized and unenforced reasonable pricing requirements imposed upon patents deriving in whole or in part from federally funded research. Tulane Law Rev. 2001;75:631-693.
7. Colaianni A, Cook-Deegan R. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act. Milbank Q. 2009;87(3):683-715.
8. Rooksby JH. Myriad choices: university patents under the sun. J Law Educ. 2013;42(2):313-326.